Evidence map›Paper›PMID 37612414›Full record

ReviewNature reviews. Molecular cell biology2023

The molecular basis of nutrient sensing and signalling by mTORC1 in metabolism regulation and disease.

Claire Goul, Roberta Peruzzo, Roberto Zoncu

Erratum issuedAbstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Molecular cell biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 160 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
160citing papers in PubMed, 1 pooled it
32.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

160 citing papers in PubMed, 1 synthesis or guideline pooled it, 205 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. The role of mTORC2/RICTOR in immune cells and inflammatory diseases.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Autophagy modulation in cancer.Nature reviews. Drug discovery · 2026
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

100 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Claire Goul *Department of Molecular and Cell Biology, University of California, Berkeley, CA, USA.
Roberta Peruzzo *Department of Molecular and Cell Biology, University of California, Berkeley, CA, USA.ORCID 0000-0001-9209-9068
Roberto ZoncuDepartment of Molecular and Cell Biology, University of California, Berkeley, CA, USA. rzoncu@berkeley.edu.ORCID 0000-0003-1611-1891
University of California, Berkeley · US

Funding

Dissecting and targeting lysosomal signaling in kidney tumorigenesisR01CA260205 · NCI · UNIVERSITY OF CALIFORNIA BERKELEY · PI ANDREA BALLABIO, Roberto Zoncu · 2022 to 2026
$2.7M
NCI NIH HHS R01 CA260205
6 · The paper itself

Abstract

The Ser/Thr kinase mechanistic target of rapamycin (mTOR) is a central regulator of cellular metabolism. As part of mTOR complex 1 (mTORC1), mTOR integrates signals such as the levels of nutrients, growth factors, energy sources and oxygen, and triggers responses that either boost anabolism or suppress catabolism. mTORC1 signalling has wide-ranging consequences for the growth and homeostasis of key tissues and organs, and its dysregulated activity promotes cancer, type 2 diabetes, neurodegeneration and other age-related disorders. How mTORC1 integrates numerous upstream cues and translates them into specific downstream responses is an outstanding question with major implications for our understanding of physiology and disease mechanisms. In this Review, we discuss recent structural and functional insights into the molecular architecture of mTORC1 and its lysosomal partners, which have greatly increased our mechanistic understanding of nutrient-dependent mTORC1 regulation. We also discuss the emerging involvement of aberrant nutrient-mTORC1 signalling in multiple diseases.

Indexed as

Diabetes Mellitus, Type 2Multiprotein ComplexesHumansMechanistic Target of Rapamycin Complex 1NutrientsTOR Serine-Threonine KinasesMechanistic Target of Rapamycin Complex 1Multiprotein ComplexesNutrientsTOR Serine-Threonine Kinases

Identifiers

PMID37612414
OpenAlexW4386098024

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.